The Board has remanded the case due to incomplete development regarding service connection for chronic myelogenous leukemia (CML), including exposure to ionizing radiation or toxins. The claim will be further developed under the PACT Act and 38 C.F.R. § 3.311.
The deciding factor: The claim is remanded because the evidence does not fully support a determination of service connection for chronic myelogenous leukemia (CML) due to exposure to ionizing radiation or toxins, and further development under the PACT Act and 38 C.F.R. § 3.311 is required.
- Claimed conditions
- chronic myelogenous leukemia (CML)
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 13, 2023
- Citation
- A23031706
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A23031706.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Board denied service connection for chronic myelogenous leukemia, finding that the Veteran's current diagnosis is not related to his in-service herbicide exposure.
- Whole decision: Granted
The Veteran's chronic myelogenous leukemia (CML) is found to be related to his service exposure to herbicide agents, specifically Agent Orange. The Board granted the claim after finding that the evidence was in equipoise as to whether the condition was due to service.
- Whole decision: Remanded (sent back)
The Board remands the claims for service connection for chronic myelogenous leukemia (CML) and common variable immunodeficiency (CVID) due to insufficient medical opinions regarding their etiology.
- Whole decision: Dismissed
The claims for service connection for migraine headaches and a higher rating for chronic myelogenous leukemia (CML) were dismissed due to an impermissible concurrent election of review options.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.